BonnieLeeApplewhiteMD

Adult Psychiatrist

Dr. Applewhite is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

I am a board-certified psychiatrist who treats patients over 18 years in an outpatient setting. I completed my B.A. At Washington University in St. Louis in 2005 with concentrations in Spanish and International Studies. I speak both Spanish and Portuguese fluently. I achieved my M.D. from St. Louis University School of Medicine in 2009. I was granted achievement awards in both Psychiatry and Infectious Disease at graduation. I completed my Psychiatry residency at Washington University School of Medicine in 2013. I have conducted research in vaccine development (T. cruzi), collaborative care in Mental Health, medication trials among patients with Parkinson's Disease (Pimavanserin), and the treatment of psychogenic movement disorders. My practice offers outpatient treatment with medication management and evidence-based psychotherapeutic modalities.

Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2009 - 2013
Saint Louis University School of MedicineClass of 2009
Washington University in St. LouisBA, Spanish and International Studies, 2001 - 2005

Morton M. Weber Award for Excellence in Infectious Disease Saint Louis University School of Medicine, 2009
Samuel W. Fordyce Award for Excellence in Psychiatry 2009
Phi Beta Kappa Washington University in St. Louis, 2005
Sigma Delta Pi National Collegiate Hispanic Honor Society Washington University in St. Louis, 2004-2005
Golden Key International Honor Society Washington University in St. Louis, 2003-2005
Louis G. Zelson Award for Excellence in Psychiatry Washington University in St. Louis, 2004
Join now to see all

Books/Book Chapters

Psychogenic Movement Disorders and Other Movement Disorders
Chapter: Pharmacotherapy
Page 284 - 288Black KJ, Applewhite BLEditors: Hallett M, Lang AE.Cambridge University Press, New York2011

Lectures

"The impact of a collaborative care model on the management of mental illness in a primary care setting."
Washington University School of Medicine - 4/2013

Co-Investigator"A Multi-Centered, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease."2011 - 2011
Junior Investigator"Induction of protective mucosal and systemic Trypanosoma cruzi immunity with liposomal Trans-Sialidase recombinant protein and CpG oligodeoxynucleotide administration."2006 - 2006